Harmony Transcatheter Pulmonary Valve System
PMA P200046
Active
Valid until
No expiry
FDA recalls
2 ongoingDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA PMAAPPR | NumberP200046 | Date26 Mar 2021 | StatusActive |
Recalls
-
- Ongoing Z-2624-2026
Devices containing inner shaft assemblies from specific manufacturing lots may have an increased potential for distal tip detachment from the delivery system under certain procedural or anatomical conditions due to a manufacturing issue.
-
- Ongoing Z-0927-2022
There is potential for the capsule bond to break during the procedure.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA PMA Active
Specification
- Full name
- Harmony TPV System
- Generic name
- Pulmonary valve prosthesis percutaneously delivered
- PMA number
- FDA product code
- NPV
- Device class
- Unclassified
- Advisory committee
- Cardiovascular
- FDA decision
- APPR Approved
Overview
AI-generated summary, 18 Sep 2026
The Harmony Transcatheter Pulmonary Valve System is a percutaneous pulmonary valve prosthesis designed for transcatheter implantation. It is intended for patients with severe pulmonary regurgitation, including those with a native or surgically repaired right ventricular outflow tract who require surgical pulmonary valve replacement.
This device is supplied sterile and intended for single-use. It is delivered via catheter-based techniques and is approved for use in pediatric and adult patients. The system is regulated under FDA PMA (Premarket Approval) and falls under the NPV product code for pulmonary valve prostheses. No MRI safety information is specified in the data.
Other devices from Medtronic, Inc.
Questions
AI-generated answers, 18 Sep 2026
What is the Harmony TPV System used for in clinical practice, and who are the intended patients?
The Harmony TPV System is a percutaneous pulmonary valve prosthesis designed for patients with severe pulmonary regurgitation, specifically those who have a native or surgically repaired right ventricular outflow tract and require surgical pulmonary valve replacement. It is approved for use in both pediatric and adult patients, as determined by echocardiography or cardiac MRI showing a pulmonary regurgitant fraction of 30% or higher.
Is the Harmony TPV System intended for single-use or repeat use, and how is it supplied?
The Harmony TPV System is supplied sterile and intended for single-use only. It is delivered via catheter-based techniques, meaning it is implanted through a minimally invasive procedure without the need for open surgery.
What regulatory pathway does the Harmony TPV System follow, and how does this affect its availability?
The Harmony TPV System follows the FDA Premarket Approval (PMA) pathway, indicated by the PMA number P200046. This approval confirms its safety and effectiveness for the specified use in managing severe pulmonary regurgitation in eligible patients. Availability is governed by this regulatory clearance.
Can the Harmony TPV System be used in patients who have had prior surgical interventions on their right ventricular outflow tract?
Yes, the Harmony TPV System is explicitly designed for patients with a native or surgically repaired right ventricular outflow tract. This includes those who have undergone prior surgical interventions requiring pulmonary valve replacement, as long as they meet the criteria for severe pulmonary regurgitation.
Are there any specific MRI safety considerations mentioned for the Harmony TPV System?
The provided data does not specify any MRI safety information for the Harmony TPV System. Clinicians should consult the device labeling or manufacturer guidance for MRI-related precautions before exposing patients to MRI environments.